Impedance cardiography (ICG) noninvasive hemodynamic monitoring provides an opportunity to deliver cost effective, quality care for patients with cardiovascular disorders.
Hemodynamic evaluation is an essential component in diagnosing cardiovascular disorders and managing patient care. There are numerous invasive, semi-invasive, and noninvasive methods available for evaluating hemodynamic function, which vary widely in equipment, procedural complexity, cost, quality of data, and risks. This paper summarizes information needed for administrative decision-making about employing one method--ICG hemodynamic monitoring--and provides an overview of the technology, its accuracy and reproducibility, clinical applications, financial consideration and references for further evaluation of the technology.
Pranulis
M F
MF
CardioDynamics International Corporation, San Diego, CA, USA.
D002307:Cardiography, Impedance / Q000191:economics / Q000592:standards*; D002318:Cardiovascular Diseases / Q000175:diagnosis*; D003362:Cost-Benefit Analysis; D020000:Decision Support Systems, Clinical; D006439:Hemodynamics; D006801:Humans; D008991:Monitoring, Physiologic / Q000379:methods; D011787:Quality of Health Care; D015203:Reproducibility of Results; D013673:Technology Assessment, Biomedical; D014481:United States